Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Enzon, Inc. (ENZN)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: ENZN
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Comments on ENZN
Baupost to Purchase More Facet Biotech: What About Biogen Idec?
[View article]
Tickerspy doesn't include all of an investor's disclosed positions. You can see all of the positions that Baupost has disclosed here...
More »
Comment by
Value Seeker
Dec 18 10:04 am
|
Rating:
+1
0
Baupost to Purchase More Facet Biotech: What About Biogen Idec?
[View article]
With a tendered offer of $1.05 above the current share price, I don't think you could ask for a greater margin of safety with a buyout...
More »
Comment by
Charto
Dec 18 08:08 am
|
Rating:
0
0
Baupost Trims Syneron Stake
[View article]
Readers please note that Baupost did *not* buy more Enzon. This article's title is wrong and should solely be about Syneron.
Comment by
Market Folly
Dec 10 22:01 pm
|
Rating:
+1
0
Baupost Trims Syneron Stake
[View article]
Do you have a cite on Baupost's 20% annual returns? I've heard the number before, but I am not sure it's accurate.
Comment by
DaveinHackensack
Dec 10 04:01 am
|
Rating:
0
0
Three Recent Biotech Activist Wins by Carl Icahn
[View article]
HAPPY THANKSGIVING MIKE BECKER. I THOUGHT SOMEHOW, I COULD REACH THE EXPERIENCED WRITERS MIND, ON 'MRNA'. THERE HAS BEEN, A SEVERE...
More »
Comment by
jimmy Turano
Nov 25 08:34 am
|
Rating:
+1
0
Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note
[View article]
Was the cat fight really necessary? This about investing.
Comment by
Geebo
Nov 23 15:17 pm
|
Rating:
+1
-1
Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note
[View article]
Who are you? The cap of the world? Daniel was nice to provide a link to something that is otherwise unreachable and as you said no...
More »
Comment by
MateState
Nov 19 12:27 pm
|
Rating:
0
-1
Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note
[View article]
Point taken. Thanks for the response Daniel. On Nov 18 01:40 PM Daniel Eskin wrote: > Greetings Dividend Inc, > > It seems odd...
More »
Comment by
Dividend Inc
Nov 18 14:42 pm
|
Rating:
0
0
Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note
[View article]
I have an original copy of Margin Of Safety, which sells for .....hold on....$700 on the net. It is an awesome work of finance. I think...
More »
Comment by
roy piper
Nov 18 13:44 pm
|
Rating:
0
0
Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note
[View article]
Check out www.gurufocus.com for summaries of returns of all well known financial firms - this one is definitely on there. On Nov 18...
More »
Comment by
Daniel Eskin
Nov 18 13:41 pm
|
Rating:
0
0
Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note
[View article]
Greetings Dividend Inc, It seems odd that you're highly concerned with what e-mail address I'm using for personal reasons and that...
More »
Comment by
Daniel Eskin
Nov 18 13:40 pm
|
Rating:
+1
-2
Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note
[View article]
does anyone know what Baupost's 2008 return was? I have not seen that number anywhere. Given his limited interest in shorting and his...
More »
Comment by
Gus McRae
Nov 18 12:24 pm
|
Rating:
+1
-1
Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note
[View article]
Greetings Daniel Eskin, It seems odd to unabashedly market your blog through the use of your Deloitte email address offering material...
More »
Comment by
Dividend Inc
Nov 18 12:21 pm
|
Rating:
+3
-3
Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note
[View article]
sclem7 - clearly you're making way more than 20% annualized a year to not be trusting him =) I've been following Seth Klarman on...
More »
Comment by
Daniel Eskin
Nov 18 11:35 am
|
Rating:
+3
-1
Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note
[View article]
I wouldn't trust this guy with an old pair of my gym socks.
Comment by
sclem7
Nov 18 11:13 am
|
Rating:
+2
-1
1
2
3
4
Next Page
Baupost to Purchase More Facet Biotech: What About Biogen Idec? [View article]
Baupost to Purchase More Facet Biotech: What About Biogen Idec? [View article]
Baupost Trims Syneron Stake [View article]
Baupost Trims Syneron Stake [View article]
Three Recent Biotech Activist Wins by Carl Icahn [View article]
Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note [View article]
Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note [View article]
Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note [View article]
Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note [View article]
Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note [View article]
Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note [View article]
Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note [View article]
Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note [View article]
Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note [View article]
Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note [View article]